Substituted quinolines as antitumor agents

Details Substituted quinolines as antitumor agents Substituted quinolines as antitumor agents

2006-06-27

2006-06-27

Tsang, Cecilia J (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S160000, C544S128000, C544S062000, C544S058200, C540S597000, C540S363000

Reexamination Certificate

active

07067532

ABSTRACT:
The invention provides a compound of Formula (Ia), or a pharmaceutically acceptable salt pro-drug or solvate thereof. The invention also provides a process for the preparation of a compound of Formula (Ia), pharmaceutical compositions of a compound of Formula (Ia) and methods for the treatment or prevention of cancer comprising administering an effective amount of a compound of Formula (Ia).

REFERENCES:
patent: 3936461 (1976-02-01), Schwender et al.
patent: 4421920 (1983-12-01), Baudouin et al.
patent: 5215999 (1993-06-01), Uchida et al.
patent: 5409930 (1995-04-01), Spada et al.
patent: 5650415 (1997-07-01), Tang et al.
patent: 5656643 (1997-08-01), Spada et al.
patent: RE36256 (1999-07-01), Spada et al.
patent: 6002008 (1999-12-01), Wissner et al.
patent: 6630489 (2003-10-01), Crawley
patent: 6638945 (2003-10-01), Gibson
patent: 0 326 330 (1989-08-01), None
patent: 2 077 455 (1971-10-01), None
patent: 93/03030 (1993-02-01), None
patent: 96/09294 (1996-03-01), None
patent: 97/03069 (1997-01-01), None
patent: 97/17329 (1997-05-01), None
patent: 98/02434 (1998-01-01), None
patent: 98/13350 (1998-04-01), None
patent: 98/43960 (1998-10-01), None
patent: 99/01421 (1999-01-01), None
patent: 99/01426 (1999-01-01), None
patent: 99/35146 (1999-07-01), None
patent: 00/18740 (2000-04-01), None
patent: 00/18761 (2000-04-01), None
patent: WO 00/18740 (2000-04-01), None
patent: 00/68199 (2000-11-01), None
patent: 00/68200 (2000-11-01), None
patent: 00/68201 (2000-11-01), None
patent: 00/68201 (2000-11-01), None
Ca 137:190369, “Hair dyes containing cationic quinolinium direct dyes”, Wella A. G., DE 20204129, Aug. 29, 2002.
Ca 89:117684, “Hydroxyethylnicotinamide vector for therapeutically active acids”, Cousse et. al., Travaux de la Societe de Pharmacie de Montpellier, 1978, 38 (1), 71-6.

Affiliated with

Also associated with

Rating

Substituted quinolines as antitumor agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted quinolines as antitumor agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinolines as antitumor agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3662101